Logo image of HSAI

HESAI GROUP (HSAI) Stock Fundamental Analysis

NASDAQ:HSAI - Nasdaq - US4280501085 - ADR - Currency: USD

25.59  +2.27 (+9.73%)

After market: 25.66 +0.07 (+0.27%)

Fundamental Rating

4

Overall HSAI gets a fundamental rating of 4 out of 10. We evaluated HSAI against 80 industry peers in the Automobile Components industry. HSAI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HSAI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HSAI was profitable.
In the past 5 years HSAI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: HSAI reported negative operating cash flow in multiple years.
HSAI Yearly Net Income VS EBIT VS OCF VS FCFHSAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

The Return On Assets of HSAI (-0.23%) is worse than 73.75% of its industry peers.
The Return On Equity of HSAI (-0.31%) is worse than 71.25% of its industry peers.
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROIC N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
HSAI Yearly ROA, ROE, ROICHSAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

HSAI has a better Gross Margin (42.99%) than 97.50% of its industry peers.
In the last couple of years the Gross Margin of HSAI has declined.
HSAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
HSAI Yearly Profit, Operating, Gross MarginsHSAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

6

2. Health

2.1 Basic Checks

HSAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSAI has less shares outstanding than it did 1 year ago.
HSAI has more shares outstanding than it did 5 years ago.
HSAI has a worse debt/assets ratio than last year.
HSAI Yearly Shares OutstandingHSAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HSAI Yearly Total Debt VS Total AssetsHSAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

HSAI has an Altman-Z score of 8.79. This indicates that HSAI is financially healthy and has little risk of bankruptcy at the moment.
HSAI's Altman-Z score of 8.79 is amongst the best of the industry. HSAI outperforms 92.50% of its industry peers.
HSAI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
HSAI has a better Debt to Equity ratio (0.08) than 88.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 8.79
ROIC/WACCN/A
WACC7.96%
HSAI Yearly LT Debt VS Equity VS FCFHSAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 4.06 indicates that HSAI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.06, HSAI belongs to the top of the industry, outperforming 91.25% of the companies in the same industry.
HSAI has a Quick Ratio of 3.62. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
HSAI has a better Quick ratio (3.62) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.62
HSAI Yearly Current Assets VS Current LiabilitesHSAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

HSAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.02%, which is quite impressive.
The Revenue has grown by 24.20% in the past year. This is a very strong growth!
The Revenue has been growing by 42.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%

3.2 Future

HSAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 215.76% yearly.
The Revenue is expected to grow by 40.14% on average over the next years. This is a very strong growth
EPS Next Y5162.61%
EPS Next 2Y965.58%
EPS Next 3Y464.61%
EPS Next 5Y215.76%
Revenue Next Year56.29%
Revenue Next 2Y50.07%
Revenue Next 3Y42.88%
Revenue Next 5Y40.14%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HSAI Yearly Revenue VS EstimatesHSAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
HSAI Yearly EPS VS EstimatesHSAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 284.33 indicates a quite expensive valuation of HSAI.
Compared to the rest of the industry, the Price/Earnings ratio of HSAI indicates a rather expensive valuation: HSAI more expensive than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.87. HSAI is valued rather expensively when compared to this.
HSAI is valuated quite expensively with a Price/Forward Earnings ratio of 40.40.
HSAI's Price/Forward Earnings ratio is rather expensive when compared to the industry. HSAI is more expensive than 80.00% of the companies in the same industry.
HSAI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.34.
Industry RankSector Rank
PE 284.33
Fwd PE 40.4
HSAI Price Earnings VS Forward Price EarningsHSAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

83.75% of the companies in the same industry are cheaper than HSAI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 688.86
HSAI Per share dataHSAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

HSAI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HSAI's earnings are expected to grow with 464.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y965.58%
EPS Next 3Y464.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HESAI GROUP

NASDAQ:HSAI (8/15/2025, 8:27:17 PM)

After market: 25.66 +0.07 (+0.27%)

25.59

+2.27 (+9.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-26 2025-05-26/amc
Earnings (Next)08-18 2025-08-18
Inst Owners58.53%
Inst Owner Change3.07%
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap3.39B
Analysts87.27
Price Target25.79 (0.78%)
Short Float %5.1%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)66.12%
Min EPS beat(2)-13.01%
Max EPS beat(2)145.25%
EPS beat(4)2
Avg EPS beat(4)10.14%
Min EPS beat(4)-108.33%
Max EPS beat(4)145.25%
EPS beat(8)6
Avg EPS beat(8)21.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.85%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-2.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)8.02%
Revenue beat(8)4
Avg Revenue beat(8)2.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.4%
PT rev (3m)8.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-3.45%
Valuation
Industry RankSector Rank
PE 284.33
Fwd PE 40.4
P/S 10.84
P/FCF N/A
P/OCF N/A
P/B 5.68
P/tB 5.79
EV/EBITDA 688.86
EPS(TTM)0.09
EY0.35%
EPS(NY)0.63
Fwd EY2.48%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.36
BVpS4.5
TBVpS4.42
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.99%
FCFM N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 10.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.62
Altman-Z 8.79
F-ScoreN/A
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)378.06%
Cap/Depr(5y)506.05%
Cap/Sales(3y)18.38%
Cap/Sales(5y)22.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y5162.61%
EPS Next 2Y965.58%
EPS Next 3Y464.61%
EPS Next 5Y215.76%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%
Revenue Next Year56.29%
Revenue Next 2Y50.07%
Revenue Next 3Y42.88%
Revenue Next 5Y40.14%
EBIT growth 1Y82.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year268%
EBIT Next 3Y90.81%
EBIT Next 5Y71.4%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.77%
OCF growth 3YN/A
OCF growth 5Y6.75%